In vitro perforation of human epithelial carcinoma cell with antibody-conjugated biodegradable microspheres illuminated by a single 80 femtosecond near-infrared laser pulse.
Pulsed laser interaction with small metallic and dielectric particles has been receiving attention as a method of drug delivery to many cells. However, most of the particles are attended by many risks, which are mainly dependent upon particle size. Unlike other widely used particles, biodegradable particles have advantages of being broken down and eliminated by innate metabolic processes. In this paper, the perforation of cell membrane by a focused spot with transparent biodegradable microspheres excited by a single 800 nm, 80 fs laser pulse is demonstrated. A polylactic acid (PLA) sphere, a biodegradable polymer, was used. Fluorescein isothiocyanate (FITC)-dextran and short interfering RNA were delivered into many human epithelial carcinoma cells (A431 cells) by applying a single 80 fs laser pulse in the presence of antibody-conjugated PLA microspheres. The focused intensity was also simulated by the three-dimensional finite-difference time-domain method. Perforation by biodegradable spheres compared with other particles has the potential to be a much safer phototherapy and drug delivery method for patients. The present method can open a new avenue, which is considered an efficient adherent for the selective perforation of cells which express the specific antigen on the cell membrane.
Department of Electronics and Electrical Engineering, Keio University, Yokohama, Kanagawa, Japan. terakawa@elec.keio.ac.jp
Mitsuhiro
M
Terakawa
Yasuyuki
Y
Tsunoi
Tatsuki
T
Mitsuhashi
D000906:Antibodies / Q000008:administration & dosage / Q000737:chemistry / Q000378:metabolism; D000970:Antineoplastic Agents / Q000737:chemistry / Q000378:metabolism; D002277:Carcinoma / Q000737:chemistry* / Q000188:drug therapy / Q000378:metabolism; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000528:radiation effects*; D016503:Drug Delivery Systems / Q000379:methods*; D066246:ErbB Receptors / Q000737:chemistry / Q000378:metabolism; D016650:Fluorescein-5-isothiocyanate / Q000737:chemistry; D006801:Humans; D019344:Lactic Acid / Q000008:administration & dosage / Q000737:chemistry*; D007834:Lasers; D008856:Microscopy, Fluorescence; D008858:Microscopy, Phase-Contrast; D008863:Microspheres; D011091:Polyesters; D011108:Polymers / Q000008:administration & dosage / Q000737:chemistry*; D034741:RNA, Small Interfering / Q000737:chemistry / Q000378:metabolism; D014162:Transfection / Q000379:methods*
D000906:Antibodies; D000970:Antineoplastic Agents; D011091:Polyesters; D011108:Polymers; D034741:RNA, Small Interfering; D019344:Lactic Acid; C033616:poly(lactide); C512478:EGFR protein, human; D066246:ErbB Receptors; D016650:Fluorescein-5-isothiocyanate